Natural Alternatives International Inc (NAII) stock
NAIINasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends June 30
$0.88−0.02 (-2.67%)
Close on Nov 20, 2026Market cap $19.37MP/E –Yield –
Natural Alternatives International revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Natural Alternatives International's revenue for the twelve months ending Jun 30, 2026 was $142.52M, up 9.7% year over year. For fiscal 2026 it was $142.52M, up 9.7% from the year before. Over ten years it grew 2.2% a year on average. The highest annual figure on record is $178.52M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $142.52M | +9.7% |
| FY2025 | Jun 30, 2025 | $129.86M | +14.1% |
| FY2024 | Jun 30, 2024 | $113.80M | -26.1% |
| FY2023 | Jun 30, 2023 | $154.02M | -9.9% |
| FY2022 | Jun 30, 2022 | $170.97M | -4.2% |
| FY2021 | Jun 30, 2021 | $178.52M | +50.2% |
| FY2020 | Jun 30, 2020 | $118.88M | -14.0% |
| FY2019 | Jun 30, 2019 | $138.29M | +4.4% |
| FY2018 | Jun 30, 2018 | $132.44M | +8.6% |
| FY2017 | Jun 30, 2017 | $121.95M | +6.8% |
| FY2016 | Jun 30, 2016 | $114.20M | +43.6% |
| FY2015 | Jun 30, 2015 | $79.51M | +7.5% |
| FY2014 | Jun 30, 2014 | $73.94M | +17.7% |
| FY2013 | Jun 30, 2013 | $62.80M | -13.8% |
| FY2012 | Jun 30, 2012 | $72.82M | +30.3% |
| FY2011 | Jun 30, 2011 | $55.88M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $34.51M | +1.9% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $35.48M | +23.3% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $34.80M | +2.1% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $37.73M | +13.8% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $33.87M | +14.8% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $28.77M | +14.4% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $34.08M | +35.2% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $33.15M | -2.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $29.49M | -17.8% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $25.14M | -23.1% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $25.20M | -40.4% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $33.97M | -21.2% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $35.89M | -31.7% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $32.70M | -22.8% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $42.30M | +12.1% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $43.13M | +12.5% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $52.53M | +18.3% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $42.37M | -8.5% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $37.73M | -21.5% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $38.34M | -3.5% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $44.39M | +26.5% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $46.32M | +81.8% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $48.08M | +65.2% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $39.73M | +36.1% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $35.10M | +16.0% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $25.48M | -28.1% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $29.10M | -19.3% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $29.20M | -20.1% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $30.26M | -22.8% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $35.46M | +11.4% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $36.04M | +8.1% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $36.53M | +30.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $39.21M | +21.8% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $31.82M | +26.6% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $33.34M | +9.1% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $28.07M | -17.6% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $32.19M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $25.14M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $30.56M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $34.07M | – |
See a number that looks wrong?